Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen ; volume:13 ; number:1 ; day:31 ; month:10 ; year:2013 ; pages:1-7 ; date:12.2013
BMC cancer ; 13, Heft 1 (31.10.2013), 1-7, 12.2013
- Creator
-
Bearz, Alessandra
- Contributor
-
Minatel, Emilio
Rumeileh, Imad Abu
Borsatti, Eugenio
Talamini, Renato
Franchin, Giovanni
Gobitti, Carlo
Del Conte, Alessandro
Trovò, Marco
Baresic, Tanja
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-513
- URN
-
urn:nbn:de:1111-201603046175
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bearz, Alessandra
- Minatel, Emilio
- Rumeileh, Imad Abu
- Borsatti, Eugenio
- Talamini, Renato
- Franchin, Giovanni
- Gobitti, Carlo
- Del Conte, Alessandro
- Trovò, Marco
- Baresic, Tanja
- SpringerLink (Online service)
Other Objects (12)
Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
What does a modified-Fibonacci dose-escalation actually correspond to?
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
What does a modified-Fibonacci dose-escalation actually correspond to?
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
What does a modified-Fibonacci dose-escalation actually correspond to?
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress